Cargando…
Nanoparticles for mucosal vaccine delivery
Mucosal surfaces represent important routes of entry into the human body for the majority of pathogens, and they constitute unique sites for targeted vaccine delivery. Nanoparticle-based drug delivery systems are emerging technologies for delivering and improving the efficacy of mucosal vaccines. Re...
Autores principales: | Thakur, Aneesh, Foged, Camilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329122/ http://dx.doi.org/10.1016/B978-0-08-102985-5.00025-5 |
Ejemplares similares
-
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
por: Wadhwa, Abishek, et al.
Publicado: (2020) -
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
por: Lokras, Abhijeet, et al.
Publicado: (2021) -
The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies
por: Frederiksen, Lea Skak Filtenborg, et al.
Publicado: (2020) -
Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects
por: Xu, You, et al.
Publicado: (2021) -
Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization
por: Thakur, Aneesh, et al.
Publicado: (2018)